Impact of polychlorinated biphenyls contamination on estrogenic activity in human male serum

Environmental Health Perspectives

Volumn 113, Issue 10, 2005, Pages 1277-1284

  Plíškova, Martina ^a   Vondráček, Jan ^a,b   Canton, Rocio Fernandez ^c   Nera, Jiří ^a   Kočan, Anton ^d   Petrík, Ján ^d   Trnovec, Tomáš ^d   Sanderson, Thomas ^c   van der Berg, Martin ^c   Machala, Miroslav ^a  

^a VETERINARY RESEARCH INSTITUTE   (Czech Republic)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c UTRECHT UNIVERSITY   (Netherlands)

^d SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

CYP1A1; CYP1B1; Dioxin like activity; Estradiol; Estrogenicity; Human serum; Polychlorinated biphenyls

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 2,2',4,4',5,5' HEXACHLOROBIPHENYL; 2,3',4,4' TETRACHLOROBIPHENYL; 3,3',4,4',5 PENTACHLOROBIPHENYL; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DIOXIN; ESTRADIOL; ESTROGEN RECEPTOR; HEXACHLOROBENZENE; MESSENGER RNA; POLYCHLORINATED BIPHENYL;

ARTICLE; BIOASSAY; CHLORINATION; CONTROLLED STUDY; CORRELATION FUNCTION; ENVIRONMENTAL EXPOSURE; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE; MALE; ORGANIC POLLUTION; PREVALENCE; PRIORITY JOURNAL; SLOVAKIA;

ENVIRONMENTAL POLLUTANTS; ESTRADIOL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; POLYCHLORINATED BIPHENYLS; RECEPTORS, ARYL HYDROCARBON; SLOVAKIA;

EID: 27244440761     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.7745     Document Type: Article

References (58)

1. Arcaro KF, Yi L, Seegal RF, Vakharia DD, Yang Y, Spink DC, et al. 1999. 2,2′,6,6′.Tetrachlorobiphenyl is estrogenic in vitro and in vivo. J Cell Biochem 72:94-102.
2. Badawi AF, Cavalieri EL, Rogan EG. 2000. Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17β-estradiol in female Sprague-Dawley rats. Carcinogenesis 21:1593-1599.
3. Bonenfeld-Jorgensen EC, Andersen HR, Rasmussen TH, Vinggaard AM. 2001. Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity. Toxicology 158:141-153.
4. Brouwer A, Longnecker MP, Birnbaum LS, Cogliano J, Kostyniak P, Moore J, et al. 1999. Characterization of potential endocrine-related health effects at low-dose levels of exposure to PCBs. Environ Health Perspect 107(suppl 4):639-649.
5. Buchanan DL, Ohsako S, Tohyama C, Cooke PS, Iguchi T. 2002. Dioxin inhibition of estrogen-induced mouse uterine epithelial mitogenesis involves changes in cyclin and transforming growth factor-beta expression. Toxicol Sci 66:62-68.
6. Buchanan DL, Sato T, Peterson RE, Cooke PS. 2000. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse uterus: critical role of the aryl hydrocarbon receptor in stromal tissue. Toxicol Sci 57:302-311.
7. Canton RF, Besselink HT, Sanderson JT, Botschuyver S, Brouwer B, van den Berg M. 2003. Expression of CYP1A and 1B1 mRNA in blood lymphocytes from two district populations in Slovakia compared to total TEQs in blood as measured by the DRE-CALUX® assay. Organohalogen Compounds 64:215-218.
8. Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, et al. 2003. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 12:1410-1416.
9. Cooke PS, Sato T, Buchanan DL. 2001. Disruption of steroid hormone signaling by PCBs. In: PCBs. Recent Advances in Environmental Toxicology and Health Effects (Robertson LW, Hansen LG, eds). Lexington, KY:University Press of Kentucky, 257-263.
10. Daston GP, Cook JC, Kavlock RJ. 2003. Uncertainties for endocrine disrupters: our view on progress. Toxicol Sci 74:245-252.
11. Fernandez MF, Rivas A, Olea-Serrano F, Cerrillo I, Molina-Molina JM, Araque P, et al. 2004. Assessment of total effective xenoestrogen burden in adipose tissue and identification of chemicals responsible for the combined estrogenic effect. Anal Bioanal Chem 379:163-170.
12. Gierthy JF, Spink BC, Figge HL, Pentecost BT, Spink DC. 1996. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 12-O-tetradecanoylphorbol-13-acetate and 17β-estradiol on estrogen receptor regulation in MCF-7 human breast cancer cells. J Cell Biochem 60:173-184.
13. Gillette JS, Hansen LG, Rose RL. 2002. Metabolic effects of episodic polychlorinated biphenyl (PCB) congeners. Rev Toxicol Environ Toxicol 4:129-159.
14. Hanaoka T, Yamano Y, Pan G, Hara K, Ichiba M, Zhang J, et al. 2002. Cytochrome P450 1B1 mRNA levels in peripheral blood cells and exposure to polycyclic aromatic hydrocarbons in Chinese coke oven workers. Sci Total Environ 296:27-33.
15. Hansen LG. 1998. Stepping backward to improve assessment of PCB congener toxicities. Environ Health Perspect 106(suppl 1):171-189.
16. Hany J, Lilienthal H, Sarasin A, Roth-Härer A, Fastabend A, Dunemann L, et al. 1999. Developmental exposure of rats to a reconstituted PCB mixture or Aroclor 1254: effects on organ weights, aromatase activity, sex hormone levels, and sweet preference behavior. Toxicol Appl Pharmacol 158:231-243.
17. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 1996. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 93:9776-9781.
18. Hovander L, Linderholm L, Athanasiadou M, Athanassiadis I, Trnovec T, Kočan A. 2004. Analysis of PCB and PCB metabolites in humans from eastern Slovakia. Organohalogen Compounds 66:3525-3531.
19. Jansen HT, Cooke PS, Porcelli J, Liu T-C, Hansen LG. 1993. Estrogenic and antiestrogenic actions of PCBs in the female rat: in vitro and in vivo studies. Reprod Toxicol 7:237-248.
20. Kočan A, Drobná B, Petrík J, Jursa S, Chovancová J, Čonka K, et al. 2004. Human exposure to PCBs and some other persistent organochlorines in eastern Slovakia as a consequence of former PCB production. Organohalogen Compounds 66:3539-3546.
21. Kočan A, Petrík J, Jursa S, Chovancová J, Drobná B. 2001. Environmental contamination with polychlorinated biphenyls in the area of their former manufacture in Slovakia. Chemosphere 43:595-600.
22. Legler J, van den Brink CE, Brouwer A, Murk AJ, van der Saag PT, Vethaak AD, et al. 1999. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 48:55-66.
23. Letcher RJ, Lemmen JG, van der Burg B, Brouwer A, Bergman A, Giesy JP, et al. 2002. In vitro antiestrogenic effects of aryl methyl sulfone metabolites of polychlorinated biphenyls and 2,2-bis(4-chlorophenyl)-1,1-dichloroethene on 17 beta-estradiol-induced gene expression in several bioassay systems. Toxicol Sci 69:362-372.
24. Li M-H, Hansen LG. 1996. Responses of prepubertal female rats to environmental PCBs with high and low dioxin equivalencies. Fundam Appl Toxicol 33:282-293.
25. Li M-H, Zhao Y-D, Hansen LG. 1994. Multiple dose toxicokinetic influence on the estrogenicity of 2,2′,4,4′,5,5′-hexachlorobiphenyl. Bull Environ Contam Toxicol 53:583-590.
26. Machala M, Blàha L, Lehmler H-J, Plíšková M, Májková Z, Kapplová P, et al. 2004. Toxicity of hydroxylated and quinoid PCB metabolites: inhibition of gap junctional intercellular communication and activation of aryl hydrocarbon and estrogen receptors in hepatic and mammary cells. Chem Res Toxicol 17:340-347.
27. Machala M, Blàha L, Vondráček J, Trosko JE, Scott J, Upham BL. 2003. Inhibition of gap junctional intercellular communication by noncoplanar polychlorinated biphenyls: inhibitory potencies and screening for potential mode(s) of action. Toxicol Sci 76:102-111.
28. Moore M, Mustain M, Daniel K, Chen I, Safe S, Zacharewski T, et al. 1997. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. Toxicol Appl Pharmacol 142:160-168.
29. Murk AJ, Legler J, Denison MS, Giesy JP, van der Guchte C, Brouwer A. 1996. Chemical-activated luciferase gene expression (CALUX): a novel in vitro bioassay for Ah receptor active compounds in sediments and pore water. Fundam Appl Toxicol 33:149-160.
30. Murk AJ, Leonards PEG, Bulder AS, Jonas AS, Rozemeijer MJC, Denison MS, et al. 1997. The CALUX (chemical-activated luciferase expression) assay, adapted and validated for measuring TCDD-equivalents in blood plasma. Environ Toxicol Chem 16:1583-1589.
31. Nesaretnam K, Darbre P. 1997. 3,5,3′,5′-tetrachlorobiphenyl is a weak oestrogen agonist in vitro and in vivo. J Steroid Biochem Mol Biol 62:409-418.
32. O'Donnell L, Robertson KM, Jones ME, Simpson ER. 2001. Estrogen and spermatogenesis. Endocr Rev 22:280-318.
33. Oenga GN, Spink DC, Carpenter DO. 2004. TCDD and PCBs inhibit breast cancer cell proliferation. Toxicol In Vitro 18:811-819.
34. Pang S, Cao JQ, Katz BH, Hayes CL, Sutter TR, Spink DC. 1999. Inductive and inhibitory effects of non-ortho-substituted polychlorinated biphenyls on estrogen metabolism and human cytochromes P450 1A1 and 1B1. Biochem Pharmacol 58:29-38.
35. Parkinson A, Robertson L, Safe L, Safe S. 1981. Polychlorinated biphenyls as inducers of hepatic microsomal enzymes: structure-activity rules. Chem Biol Interact 30:271-285.
36. Pauwels AN, Cenijn PH, Schepens PJC, Brouwer A. 2000. Comparison of chemical-activated luciferase gene expression bioassay and gas chromatography for PCB determination in human serum and follicular fluid. Environ Health Perspect 108:553-557.
37. Pavúk M, Cerhan A Lynch CF, Schecter A, Petrik J, Chovancova J, et al. 2004. Environmental exposure to PCBs and cancer incidence in eastern Slovakia. Chemosphere 54:1509-1520.
38. Ramamoorthy K, Gupta MS, Sun G, McDougal A, Safe SH. 1999. 3,3′4,4′-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells. Carcinogenesis 20:115-123.
39. Rasmussen TH, Nielsen F, Andersen HR, Nielsen JB, Weihe P, Grandjean P. 2003. Assessment of xenoestrogenic exposure by a biomarker approach: application of the E-Screen bioassay to determine estrogenic response of serum extracts. Environ Health 2:12.
40. Richthoff J, Rylander L, Jönsson BAG, Åkesson H, Hagmar L, Nilsson-Ehle P, et al. 2003. Serum levels of 2,2′,4,4′,5,5′-hexachlorobiphenyl (CB-153) in relation to markers of reproductive function in young males from the general Swedish population. Environ Health Perspect 111:409-413.
41. Robertson LW, Hansen LG. 2001. PCBs. Recent Advances in Environmental Toxicology and Health Effects. Lexington, KY:The University Press of Kentucky.
42. Rogers JM, Denison MS. 2000. Recombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals. In Vitro Mol Toxicol 13:67-82.
43. Rose RL, Khan MA, Li M-H, Gillette JS, Hansen LG. 2002. Endocrine offects of episodic polychlorinated biphenyl (PCB) congeners. Rev Toxicol Environ Toxicol 2:1-18.
44. Safe SH. 1994. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol 24:87-149.
45. Safe SH. 2004. Endocrine disruptors and human health: is there a problem? Toxicology 205:3-10.
46. Safe SH, Wörmke M. 2003. Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem Res Toxicol 16:807-816.
47. Sonnenschein C, Soto AM, Fernandez MF, Olea N, Olea-Serrano MF, Ruiz-Lopez MD. 1995. Development of a marker of estrogenic exposure in human serum. Clin Chem 41:1888-1895.
48. Soto AM, Fernandez MF, Luizzi MF, Oles Karasko AS, Sonnenschein C. 1997. Developing a marker of exposure to xenoestrogen mixtures in human serum. Environ Health Perspect 105(suppl 3):647-654.
49. Spink DC, Lincoln DW II, Dickerman HW, Gierthy JF. 1990. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17β-estradiol metabolism in MCF-7 breast tumor cells. Proc Natl Acad Sci USA. 87:6917-6921.
50. Takemoto K, Nakajima M, Fujiki Y, Katoh M, Gonzalez FJ, Yokoi T. 2004. Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Toxicol 78:309-315.
51. Trnovec T, Kočan A, Langer P, Šovčíková E, Tajtáková M, Bergman Å, et al. 2000. Project proposal. Evaluating human health risk from low-dose and long-term exposure to polychlorinated biphenyls. Endocr Regul 34:167-168.
52. van den Berg M, Birnbaum L, Bosveld AT, Brunström B, Cook P, Feeley M, et al. 1998. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 106:775-792.
53. van Duursen ME, Sanderson JT, van den Berg M. 2005. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility. Toxicol Sci 85:703-712.
54. van Duursen MB, Sanderson JT, van der Bruggen M, van der Linden J, van den Berg M. 2003. Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines. Toxicol Appl Pharmacol 190:241-250.
55. Wang WL, Smith R III, Safe S. 1998. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes. Arch Biochem Biophys 356:239-248.
56. Yamasaki K, Takeyoshi M, Yakabe Y, Sawaki M, Imatanaka N, Takatsuki M. 2002. Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. Toxicology 170:21-30.
57. Yamazaki H, Shaw PM, Guengerich FP, Shimada T. 1998. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 11:659-665.
58. Zacharewski T. 1997. In vitro bioassay for assessing estrogenic substances. Environ Sci Technol 31:613-623.